We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+12.25%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.91B
AUM Growth
+$100M
Cap. Flow
-$61.7M
Cap. Flow %
-3.22%
Top 10 Hldgs %
40.66%
Holding
350
New
52
Increased
58
Reduced
147
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 36.47%
2 Consumer Discretionary 15.93%
3 Healthcare 15.71%
4 Communication Services 8.84%
5 Financials 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QLYS icon
101
Qualys
QLYS
$6.43B
$1.05M 0.05%
10,718
-610
-5% -$65.2K
ADUS icon
102
Addus HomeCare
ADUS
$2.23B
$1M 0.05%
10,634
-374
-3% -$35K
BCC icon
103
Boise Cascade
BCC
$2.96B
$994K 0.05%
24,895
-847
-3% -$36.7K
LZB icon
104
La-Z-Boy
LZB
$1.66B
$988K 0.05%
31,239
-10
-0% -$304
MMS icon
105
Maximus
MMS
$2.9B
$977K 0.05%
14,281
+2,690
+23% +$198K
PLXS icon
106
Plexus
PLXS
$7.16B
$975K 0.05%
+13,811
New +$1.01M
IDCC icon
107
InterDigital
IDCC
$8.99B
$961K 0.05%
16,839
-10
-0.1% -$601
PRGS icon
108
Progress Software
PRGS
$1.78B
$926K 0.05%
25,252
-10
-0% -$364
EFOR
109
Everforth Inc
EFOR
$1.33B
$875K 0.05%
13,761
+5,170
+60% +$356K
EHC icon
110
Encompass Health
EHC
$12.5B
$870K 0.05%
16,825
-2,866
-15% -$147K
SUPN icon
111
Supernus Pharmaceuticals
SUPN
$2.74B
$788K 0.04%
37,798
-10
-0% -$227
PCRX icon
112
Pacira BioSciences
PCRX
$974M
$743K 0.04%
12,364
-1,958
-14% -$114K
PATK icon
113
Patrick Industries
PATK
$2.75B
$738K 0.04%
+19,233
New +$770K
AMWD
114
DELISTED
American Woodmark
AMWD
$712K 0.04%
9,070
RDY icon
115
Dr. Reddy's Laboratories
RDY
$10.1B
$683K 0.04%
49,100
-11,650
-19% -$139K
AMRX icon
116
Amneal Pharmaceuticals
AMRX
$5.71B
$674K 0.04%
173,760
-60
-0% -$257
SAM icon
117
Boston Beer
SAM
$1.86B
$667K 0.03%
755
-645
-46% -$509K
MTZ icon
118
MasTec
MTZ
$21.5B
$653K 0.03%
15,481
VAC icon
119
Marriott Vacations Worldwide
VAC
$3.89B
$626K 0.03%
+6,897
New +$626K
EAT icon
120
Brinker International
EAT
$9.76B
$616K 0.03%
14,416
-11,620
-45% -$405K
COLL icon
121
Collegium Pharmaceutical
COLL
$882M
$590K 0.03%
28,335
-3,420
-11% -$61.7K
PRAH
122
DELISTED
PRA Health Sciences, Inc.
PRAH
$586K 0.03%
5,778
MBUU icon
123
Malibu Boats
MBUU
$568M
$581K 0.03%
+11,718
New +$637K
HIBB
124
DELISTED
Hibbett, Inc. Common Stock
HIBB
$568K 0.03%
14,494
-3,720
-20% -$108K
BOX icon
125
Box
BOX
$4.65B
$556K 0.03%
+32,051
New +$592K

Similar funds

Smith Group Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Smith Group Asset Management held 350 positions worth $1.91B, up 5.5% from $1.81B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Smith Group Asset Management withdrew a net $61.7M in Q3 2020, closing 44 positions and reducing 147 holdings. Its most notable exit was Oracle, an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Smith Group Asset Management opened a new position in Thermo Fisher Scientific worth $13.7M.

  • Smith Group Asset Management's largest Q3 2020 buy was Thermo Fisher Scientific: 30,920 shares worth $13.7M.
  • Smith Group Asset Management added most to Lowe's Companies in Q3 2020, an estimated $21.7M increase.
  • Smith Group Asset Management's biggest Q3 2020 reduction was Bristol-Myers Squibb, cutting an estimated $14.5M.
  • Smith Group Asset Management fully exited Oracle in Q3 2020, selling an estimated $30.3M.
  • Smith Group Asset Management's ten largest holdings make up 41% of its $1.91B portfolio in Q3 2020.
  • Smith Group Asset Management opened 52 new positions and closed 44 in Q3 2020.
  • Smith Group Asset Management's portfolio value rose 5.5% quarter-over-quarter to $1.91B.

Based on Smith Group Asset Management's 13F filing for Q3 2020, filed 4 Nov 2020.